Home » Topics » Regulatory

Regulatory
RSS

J&J to file for two new indications for Topamax

Sep. 12, 2002

Pediatric indication approved for Zenapax

Sep. 4, 2002

Lexapro approved for treatment and maintenance treatment of major depressive disorder

Sep. 2, 2002

E.U. approval for Visudyne

Sep. 2, 2002

Neulasta approved in E.U.

Aug. 30, 2002

E.U. approval for Aranesp

Aug. 29, 2002

Ortho Tri-Cyclen Lo receives FDA approval

Aug. 26, 2002

FDA approves pediatric labeling of Prevacid

Aug. 9, 2002

Lescol sNDA filed for secondary prevention of cardiovascular events in angioplasty patients

Aug. 9, 2002

Risperdal Consta approved in Germany

Aug. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...